by Amy Berenbaum Goodman, JD, MBE, CMS Senior Director of Policy
Featured in the September-October 2019 Colorado Medicine Colorado Medicine.
The Colorado Consortium for Prescription Drug Abuse Prevention – a statewide interuniversity/interagency network whose mission is to reduce prescription drug misuse and abuse by developing policies, programs, and partnerships with collaboration and buy-in from all interested public and private stakeholders – asked the Colorado Medical Society to convene physicians across multiple specialties to develop recommendations for how to combat the opioid crisis in Colorado and to help set a coordinated strategic course for activities and programs throughout the state.
CMS has worked closely with the Consortium since its inception to help reverse the crisis. In this work, CMS has prioritized access to care; physician education; guaranteeing that insurance functions for patients; and continuing to limit the dispensing and use of opioids while assuring access to compassionate, evidence-based care for patients who suffer from acute and chronic pain.
After two day-long facilitations over six months, the physician participants put forth recommendations that fall into three broad categories: prevention and early intervention, treatment, and harm reduction. The participants identified key questions for each category and developed a list of initiatives and targets with accompanying actions and strategies to address each key question. See the matrix below for the resulting recommendations.
CMS remains committed to the work of the Consortium and the goal of eradicating prescription drug misuse and abuse in Colorado. CMS and its Committee on Prescription Drug Abuse are engaged in next steps stemming from the key questions, initiatives and actions identified through the Multi-Specialty Convening on Opioids. Physicians will continue to partner with the Consortium to help reverse the opioid epidemic while providing compassionate, evidence-based care to patients who suffer from acute and chronic pain.